Trial Profile

A retrospective study to evaluate persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort Study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 07 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vilanterol/fluticasone furoate (Primary) ; Beclometasone/formoterol; Budesonide/formoterol
Indications Asthma
Focus Therapeutic Use

Most Recent Events

12 May 2020 New trial record
02 May 2020 Primary endpoint (treatment persistence (time to discontinuation)) has been met, as per rsesults published in the Advances in Therapy
02 May 2020 Results published in the Advances in Therapy

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com